Skip to content
10-Q

Quarterly Report

IGM Biosciences, Inc.

0000950170-24-123675

← back to feed
Filed
Nov 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Sep 30, 2024 60.66M sh
Shares Diluted Q3 2024 · Sep 30, 2024 60.4M sh
Shares Diluted Q3 2024 · Sep 30, 2023 59.58M sh
Shares Diluted Q3 2024 · Sep 30, 2023 49.78M sh
Capex Q3 2024 · Sep 30, 2024 $4.99M
Capex Q3 2024 · Sep 30, 2023 $10.93M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$118.18M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$144.22M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $42.88M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $112.52M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $174.79M
Stockholders Equity Q3 2024 · Sep 30, 2024 $78.95M
Stockholders Equity Q3 2024 · Jun 30, 2024 $122.36M
Stockholders Equity Q3 2024 · Mar 31, 2024 $161.25M
Stockholders Equity Q3 2024 · Dec 31, 2023 $203.23M
Stockholders Equity Q3 2024 · Sep 30, 2023 $253.86M
Stockholders Equity Q3 2024 · Jun 30, 2023 $258.61M
Stockholders Equity Q3 2024 · Mar 31, 2023 $239.43M
Stockholders Equity Q3 2024 · Dec 31, 2022 $287.26M
Current Liabilities Q3 2024 · Sep 30, 2024 $43.96M
Current Liabilities Q3 2024 · Dec 31, 2023 $42.48M
Total Liabilities Q3 2024 · Sep 30, 2024 $225.56M
Total Liabilities Q3 2024 · Dec 31, 2023 $220.18M
Current Assets Q3 2024 · Sep 30, 2024 $229.63M
Current Assets Q3 2024 · Dec 31, 2023 $347.6M
Total Assets Q3 2024 · Sep 30, 2024 $304.51M
Total Assets Q3 2024 · Dec 31, 2023 $423.41M
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.01
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.63
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.04
Eps Diluted Q3 2024 · Sep 30, 2023 −$3.73
Eps Basic Q3 2024 · Sep 30, 2024 −$1.01
Eps Basic Q3 2024 · Sep 30, 2024 −$2.63
Eps Basic Q3 2024 · Sep 30, 2023 −$1.04
Eps Basic Q3 2024 · Sep 30, 2023 −$3.73
Sga Expense Q3 2024 · Sep 30, 2024 $18.76M
Sga Expense Q3 2024 · Sep 30, 2024 $39.95M
Sga Expense Q3 2024 · Sep 30, 2023 $12.51M
Sga Expense Q3 2024 · Sep 30, 2023 $38.49M
Rd Expense Q3 2024 · Sep 30, 2024 $46.14M
Rd Expense Q3 2024 · Sep 30, 2024 $131.92M
Rd Expense Q3 2024 · Sep 30, 2023 $54.76M
Rd Expense Q3 2024 · Sep 30, 2023 $161.33M
Net Income Q3 2024 · Sep 30, 2024 −$61.43M
Net Income Q3 2024 · Sep 30, 2024 −$159.15M
Net Income Q3 2024 · Jun 30, 2024 −$47.9M
Net Income Q3 2024 · Mar 31, 2024 −$49.82M
Net Income Q3 2024 · Sep 30, 2023 −$61.99M
Net Income Q3 2024 · Sep 30, 2023 −$185.72M
Net Income Q3 2024 · Jun 30, 2023 −$64.42M
Net Income Q3 2024 · Mar 31, 2023 −$59.31M
Operating Income Q3 2024 · Sep 30, 2024 −$64.39M
Operating Income Q3 2024 · Sep 30, 2024 −$169.6M
Operating Income Q3 2024 · Sep 30, 2023 −$66.76M
Operating Income Q3 2024 · Sep 30, 2023 −$198.34M